Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Ageing Res Rev. 2023 Mar 31;87:101923. doi: 10.1016/j.arr.2023.101923

Fig. 4.

Fig. 4.

IPD meta-analyses of RCTs comparing vitamin D3 and placebo for the outcome “cancer mortality” in the general population (panel A) and for the outcomes “overall and cancer-specific survival” in cancer patients (panel B and C). Note: Unadjusted results are shown. The adjusted results are almost identical (Supplementary tables 8, 10 and 11).